Drug
Evacetrapib clinical trials
Also written LY2484595.
- studies test it
- 25
- open now
- 0
- in phase 3
- 4
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
25 studies that test it; most in 2013 (8)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 7 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 19
- Phase 2
- 2
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 0
Often tested with
Tested in the same studies.
Atorvastatin (3) · Simvastatin (2) · Ketoconazole (1) · Pravastatin (1) · Rifampin (1) · Gemfibrozil (1) · Rosuvastatin (1)
Studies
Open first, then newest update. How each study uses evacetrapib is read from its arms, and is right about nine times in ten.
Testing it · 25
- A Study of Evacetrapib (LY2484595) in Participants With High CholesterolTerminatedPhase 3Eli Lilly and CompanyNCT02227784Written as Evacetrapib
- A Study of Evacetrapib in High-Risk Vascular DiseaseTerminatedPhase 3Eli Lilly and CompanyNCT01687998Written as Evacetrapib
- A Study of LY2484595 on Pharmacokinetics in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01448824Written as LY2484595
- A Study of LY2484595 on the Electrical Activity of the HeartCompletedPhase 1Eli Lilly and CompanyNCT01537887Written as LY2484595
- A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02271425Written as Evacetrapib Tablet
- A Study of Different Particle Sizes of Evacetrapib in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02497391Written as Evacetrapib
- A Study of Evacetrapib in Healthy Japanese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02226653Written as Evacetrapib
- A Study of LY2484595 in Japanese SubjectsCompletedPhase 2Eli Lilly and CompanyNCT01375075Written as LY2484595
- Study of Food on Evacetrapib (LY2484595) in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01810432Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) ImpairmentCompletedPhase 1Eli Lilly and CompanyNCT01836185Written as Evacetrapib
- A Study of Evacetrapib With Selected Statins in Healthy Chinese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02156492Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01825889Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01825876Written as Evacetrapib
- A Study of Evacetrapib in Japanese and Non-Japanese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01958489Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01903434Written as Evacetrapib
- A Study of Evacetrapib in Healthy Female ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01746732Written as Evacetrapib
- A Study of Evacetrapib and Digoxin in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01897493Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary HypercholesterolemiaTerminatedPhase 3Eli Lilly and CompanyNCT02260648Written as Evacetrapib
- A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaTerminatedPhase 3Eli Lilly and CompanyNCT02260635Written as Evacetrapib
- A Study of Evacetrapib and Rifampin in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01908582Written as Evacetrapib
See all 25 studies that test evacetrapib →
Given in every arm · 1 — evacetrapib is usual care beside what is tested
Codes
What other systems call evacetrapib · ClinicalTrials.gg INT005927
- MeSH (NLM) C568301evacetrapibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 51XWV9K850EVACETRAPIBConfirmed FDA, NLM, Wikidata
- Wikidata Q553129evacetrapibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166804EvacetrapibOne source FDA
- DrugBank DB11655One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C568301 | evacetrapib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 51XWV9K850 | EVACETRAPIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q553129 | evacetrapib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166804 | Evacetrapib | One source FDA |
| DrugBank | DB11655 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.